The carcinoembryonic antigen (CEA) level was 8.0 ng/ml, cancer antigen15-3 (CA15-3) was 42.2 U/ml, and breast carcinoma-associated antigen225 (BCA225) was 210 U/ml, all of which were elevated. This evidence concerns the gene CEACAM5 and breast carcinoma.